Progress in Application of TNF-α Inhibitors in Immune Checkpoint Therapy

Progress in Application of TNF-α Inhibitors in Immune Checkpoint Therapy

Immune checkpoint inhibitors significantly improves the prognosis of patients with advanced malignancy, but it is also associated with off-target toxicity caused by activation of the immune system, known as immune-related adverse events (irAEs). Severe irAEs will lead to temporary or permanent termi...

Full description

Bibliographic Details
Main Authors: ZHAO Jianrong, ZHANG Xianquan
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2021-04-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
tnf-α
immune-related adverse events
immune checkpoint inhibitors
immunotherapy
infliximab
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.0862.htm

Similar Items

Similar Items